RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please share
RT @gideon_R: @JolandaTwit @ginnymooy Nope, kosten zijn laag met HCQ/AZT/Zink en Ivermectine. Kost een fractie, zeker als je de directe zk…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
🚨🔥VALUABLE INFO🔥🚨 👇👇👇
RT @zev_dr: please retweet
RT @zev_dr: please retweet
@amy4nk
RT @zev_dr: please retweet
RT @zev_dr: Please share
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: please retweet
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please share
RT @zev_dr: please retweet
RT @zev_dr: Please share
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: please retweet
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing https://t.co/ouWBFhw2rj
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
@NBCNews THE COVID-19 RESPONSE IS MEDICAL AND POLITICAL FRAUD https://t.co/wZvcd149mo Ivermectin inhibits the replication of SARS-CoV-2 in vitro https://t.co/9iPHSmFwnO Outpatient Early Treatment with Hydroxychloroquine+Zinc https://t.co/nBznaQAAX4
@NBCNews * TIME TO REVIEW YOUR HIPPOCRATIC OATH * A lot of people do NOT have to die: COVID-19 OUTPATIENT EARLY TREATMENT WITH HCQ+ZINC https://t.co/nBznaQAAX4 IVERMECTIN + HCQ + Other prophylactics KILL COVID-19 https://t.co/9iPHSmFwnO FLCCC: Ivermectin S
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: Please keep sharing
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please share
RT @zev_dr: Please keep sharing https://t.co/ouWBFhw2rj
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @ScottAdamsSays: Small study, and retrospective (not the gold standard type), but add it to your data pile. https://t.co/mwnnGoaqNa
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: Please share
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: Please keep sharing
RT @watchfulwatcher: "Can someone explain to me why a peer reviewed study in an internationally acclaimed journal that shows 84% reduction…
RT @zev_dr: please retweet
RT @zev_dr: Please keep sharing
RT @watchfulwatcher: "Can someone explain to me why a peer reviewed study in an internationally acclaimed journal that shows 84% reduction…
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: Please keep sharing https://t.co/ouWBFhw2rj
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please share
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: please retweet
RT @zev_dr: please retweet